MetLife, Inc. (NYSE:MET) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lifted its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 0.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,913,408 shares of the financial services provider's stock after purchasing an additional 30,187 shares during the period. Charles Schwab Investment Management Inc. owned about 0.57% of MetLife worth $320,430,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of MET. Steward Partners Investment Advisory LLC boosted its holdings in shares of MetLife by 25.4% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 39,179 shares of the financial services provider's stock valued at $3,208,000 after buying an additional 7,940 shares during the period. Fidelis Capital Partners LLC boosted its stake in MetLife by 7.0% in the fourth quarter. Fidelis Capital Partners LLC now owns 3,472 shares of the financial services provider's stock valued at $297,000 after acquiring an additional 228 shares during the period. SBI Securities Co. Ltd. bought a new position in shares of MetLife during the fourth quarter valued at approximately $110,000. Jones Financial Companies Lllp raised its position in shares of MetLife by 30.5% during the 4th quarter. Jones Financial Companies Lllp now owns 19,673 shares of the financial services provider's stock worth $1,611,000 after purchasing an additional 4,594 shares during the period. Finally, Modera Wealth Management LLC lifted its holdings in shares of MetLife by 6.4% in the 4th quarter. Modera Wealth Management LLC now owns 2,842 shares of the financial services provider's stock worth $233,000 after purchasing an additional 172 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Trading Up 2.0 %

Shares of MET stock opened at $83.17 on Thursday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a 50-day simple moving average of $83.74 and a 200 day simple moving average of $82.15. MetLife, Inc. has a fifty-two week low of $67.30 and a fifty-two week high of $89.05. The stock has a market capitalization of $56.66 billion, a P/E ratio of 13.93, a P/E/G ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. MetLife's dividend payout ratio (DPR) is presently 36.52%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a report on Tuesday, January 7th. Wells Fargo & Company upped their target price on shares of MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 19th. Morgan Stanley lifted their price target on MetLife from $101.00 to $109.00 and gave the company an "overweight" rating in a report on Friday, February 28th. Keefe, Bruyette & Woods decreased their price objective on MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a report on Wednesday, February 12th. Finally, BMO Capital Markets began coverage on MetLife in a research note on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $94.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.